Michael Weinblatt Profile: Michael Weinblatt Events (3) December 22, 1999: VIGOR Study Provides Clearer Evidence of Heart Problems Among Users of the Drug Vioxx 1999-12-22 February 15, 2000: Head of Vioxx Study to be Paid $60,000 to sit on Merck Advisory Board 2000-02-15 January 1999: Merck Launches VIGOR Clinical Trial of Vioxx